A smaller share of Americans with COVID-19 have been admitted to hospitals during the omicron surge than during previous waves, the Centers for Disease Control and Prevention said. From the New York Times.
A patient at the emergency department dedicated to COVID-19 patients at Brooklyn Hospital Center in New York, Jan. 12, 2022.
A patient at the emergency department dedicated to COVID-19 patients at Brooklyn Hospital Center in New York, Jan. 12, 2022. The agency tracked data up until Jan. 15, when it said that the increase in hospital admissions appeared to be slowing. Up until that point, the average number of Americans dying from COVID every day was lower than during previous waves. But the death toll has since been climbing and in recent days surpassed the peak average number of daily deaths during the delta-driven surge of cases in the fall.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
COVID-19 live updates: New Zealand imposes restrictions amid omicron outbreakNew Zealand Prime Minister Jacinda Ardern revealed that her own wedding will be postponed as she announced a new set of COVID-19 restrictions amid the country’s first omicron outbreak.
Consulte Mais informação »
A ‘Stealth’ Variant of Omicron Is Taking Over COVID-19 InfectionsEven as Omicron infections in the U.S. and have peaked, a new variant on the block will keep health authorities on tenterhooks for now. Called 'Stealth Omicron', it is one of the substrains that emerged with Omicron and is reported to be more transmissible than Omicron itself
Consulte Mais informação »
Stealth Omicron COVID variant BA.2 that may spread faster found in at least 40 countriesEarly data suggests that the BA.2 Omicron sub-variant, nicknamed 'stealth Omicron,' may have an increased growth rate compared to the variant's dominant form.
Consulte Mais informação »
FDA Curbs Use of COVID-19 Antibody Drugs Sidelined by OmicronU.S. health officials say COVID-19 antibody drugs from Regeneron and Eli Lilly should no longer be used because they are unlikely to work against the omicron variant.
Consulte Mais informação »
Clinical Trials Begin For Pfizer And BioNTech’s Omicron-Specific Covid ShotI am a London-based reporter for Forbes covering breaking news. Previously, I have worked as a reporter for a specialist legal publication covering big data and as a freelance journalist and policy analyst covering science, tech and health. I have a master’s degree in Biological Natural Sciences and a master’s degree in the History and Philosophy of Science from the University of Cambridge. Follow me on Twitter theroberthart or email me at rhartforbes.com
Consulte Mais informação »
Pfizer opens study of COVID shots updated to match omicronPfizer has begun a study comparing its original COVID-19 vaccine with doses specially tweaked to match the hugely contagious omicron variant. Pfizer...
Consulte Mais informação »